Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on children.
There are several discussions going around in the e-health sector for consolidation with key players being PharmEasy, 1mg, Medlife and Netmeds. According to reports, Reliance Jio is in talks with Netmeds to acquire the latter.
Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
If a retail investor wants exposure to a healthcare ETF, it should be a part of his satellite portfolio, suggests Sanjay Kumar Singh.
'Why should our government opt for unproven technology that has been rejected by most countries across the globe?' 'Being dependent on any other nation to supply you seed for your good crops is another form of slavery.'
The company has been developing donor-derived stem cell platforms.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.
'If we go in the same direction as them, we cannot expect a different result from them.' 'Our fall is going to be very swift.' 'Within a decade, we can expect the situation to change for the worse.'
'This is a period of significant uncertainty, of unknown unknowns.'
The study noted that humans are not protected from the G4 virus by the immunity offered by other human influenza vaccine strains, indicating that there is no preexisting population immunity to the virus.
The country is still in the ascending limb of the epidemic, said Prof D Prabhakaran.
PowerGrid was the top gainer in the Sensex pack, rallying over 4 per cent, followed by NTPC, UltraTech Cement, Tech Mahindra, Reliance Industries and IndusInd Bank.
IndusInd Bank was the top laggard in the Sensex pack, cracking around 10 per cent, followed by HDFC, Maruti Suzuki, Axis Bank and UltraTech Cement. On the other hand, TCS, Infosys, ITC and HCL Tech closed with gains. NSE Nifty plunged 313.60 points or 3.43 per cent to 8,823.25.
'Both the governments and people have to recognise that this is a long race, not a short sprint.'
OXSIGHT, founded in 2016 to create wearable technology devices based on how the brain manages visual information, began conducting trials in India two years ago in partnership with leading eye hospitals and clinics.
This was the sixth consecutive day when coronavirus cases increased by more than 14,000. Consequently, India has added 92,573 cases since June 20, and over 2.82 lakh this month alone since June 1.
Wellness tourism is travel for the purpose of promoting health and well-being through physical, psychological, or spiritual activities.
The disease could go down several paths. One possibility, the least likely, is that it will just disappear. The most likely is that it will have seasonal impact, says Devangshu Datta.
Bengaluru has emerged as the world's fastest-growing mature tech ecosystem in the world since 2016, followed by the European cities of London, Munich, Berlin and Paris, with India's financial centre of Mumbai in sixth place, according to new research released in London on Thursday.
The efficacy of the vaccine, developed by the Gamalaya Centre, was demonstrated on the basis of a first interim analysis obtained 21 days after the first injection.
'Imagine taking care of a patient who is infected with Covid. A human nurse is unable to do that due to fear of infection. The robot can do that task, while it is controlled or supervised by the human nurse. So the robot becomes an extension of the nurse.'
Patients from any part of the country will soon need to travel no more than three hours for treatment of the kind available in large metros.
'India's future: To manufacture so efficiently that we do not need protection,' says Naushad Forbes.
If we are to realise the full potential of biologics' ability to improve people's health, it is essential to encourage public policy and support R&D.
Shi explained that she and a group of researchers obtained samples of coronavirus on December 30 last year and performed high-throughput sequencing of the samples and the isolation of pathogens.
So far the coronavirus, which originated in the Chinese city of Wuhan, has infected more than 54 million people around the world and killed over 1.3 million others.
'There is no emergency of a third wave that we are rushing for booster doses.'
The number of recoveries also surged with 2,48,189 patients cured so far, while there were 1,78,014 active cases, according to the updated official figures at 8 am.
Banerjee, 58, was educated at the University of Calcutta, Jawaharlal Nehru University and Harvard University, where he received his Ph.D in 1988. He is currently the Ford Foundation International Professor of Economics at the Massachusetts Institute of Technology.
In the early part of 1800, a 30-acre plot next to Fort Gloster on the banks of river Hooghly in Howrah district of Bengal was the nerve centre of industrial activity; it housed India's first steam-powered cotton mill, Bowreah Mills, which was set up by a British merchant and went on to become a hub of factories - a rum distillery, foundry, cotton yarn factory, an oil mill and a paper mill, et al. Spearheaded by Dwarkanath Tagore, the industrialist grandfather of Rabindranath Tagore, the commercial complex was possibly the first of its kind in the country. Close to 200 years later, after much ebb and flow of history, the hub is set for a resurgence of sorts.
'There is no data to show this virus is more deadlier.'
The experts agreed that the lockdown has helped in slowing down spread of the virus but insisted that the situation has not reached a plateau and that there was an urgent need to upgrade healthcare facilities to deal with the crisis.
'That is the one headline the world is reading about India this week, and it is a potentially damaging story...' 'I don't think a panic mentality has set in, but this story is one that investors and market watchers are absolutely seized with.'
All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.
The Union health minister said of the total active COVID-19 cases in the country, 1.5 per cent are on oxygen support and 2.34 per cent are in ICUs.
'There is little doubt that India's tobacco epidemic is contributing to its TB epidemic,' says Neil W Schluger.
However, the number of confirmed cases reported by states rose by over 500 to cross 3,000 with at least 90 dead. While Maharashtra, Telangana and Delhi disclosed several new cases of the deadly virus infection, government officials said the numbers have risen in last few days mostly due to one event -- referring to the Tablighi Jamaat's religious gathering in the national capital attended by thousands of people last month.
As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.
'Worse disasters -- both natural and man-made -- have come and gone in our country. We are here because our ancestors and we survived.'
